A Preliminary Study of Polycaprolactone Filler After Hyaluronidase for Facial Overfilled Syndrome.

Authors

Zhiqiang Xue, Changwon Kim, Dahee Hwang

Published in

Clinical, cosmetic and investigational dermatology. Volume 19. Pages 615095. Epub Jun 23, 2026.

Abstract

Hyaluronidase effectively degrades hyaluronic acid (HA) fillers in facial overfilled syndrome (FOS). However, the subsequent volume reduction may create soft tissue hollowing and contour irregularities.
To evaluate the aesthetic and structural changes following polycaprolactone (PCL) filler injection after hyaluronidase treatment in patients with FOS.
This single-arm, retrospective study enrolled patients with FOS who underwent hyaluronidase treatment followed by a PCL injection. Outcomes included Global Aesthetic Improvement Scale (GAIS), upper cheek fullness, temporal hollowing, 3D midfacial volume, and ultrasound-measured soft tissue-to-bone distance. Assessments were performed at baseline, after hyaluronidase, and at 3 and 6 months post-PCL treatment.
12 patients were enrolled. At 6 months after PCL injection, improvements were observed in GAIS (P < 0.001) and upper cheek fullness (P = 0.016). Using the pre-hyaluronidase state as baseline, the 3D midfacial filler volume decreased by 2.48 mL after hyaluronidase injection (P < 0.001), by 4.88 mL at 3 months after PCL treatment (P < 0.001), and by 5.14 mL at 6 months after PCL treatment (P < 0.001). Conversely, the ultrasound-assessed distance from soft tissue to bone surface was 1.21 mm greater than baseline after hyaluronidase treatment (P < 0.001), and 2.09 mm and 3.23 mm lower than baseline at 3 and 6 months after PCL injection, respectively (both P < 0.001). No adverse events were reported after hyaluronidase and PCL treatment.
In this preliminary study, aesthetic improvement and changes in soft tissue parameters were observed after PCL injection following hyaluronidase treatment.

PMID:
42371529
Bibliographic data and abstract were imported from PubMed on 29 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.